BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.753
-0.147 (-5.08%)
Feb 24, 2026, 1:18 PM EST - Market open

BioLineRx Revenue

BioLineRx had revenue of $427.00K in the quarter ending September 30, 2025, a decrease of -91.36%. This brings the company's revenue in the last twelve months to $12.74M, down -42.09% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.

Revenue (ttm)
$12.74M
Revenue Growth
-42.09%
P/S Ratio
0.99
Revenue / Employee
$454,821
Employees
28
Market Cap
12.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.94M24.14M502.92%
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioAtla11.00M
Moolec Science7.83M
Traws Pharma2.85M
Longeveron1.44M
CytoMed Therapeutics573.19K
BioCardia3.00K
Revenue Rankings